Concepedia
Statistics
Publications
4
Citations
422
H-Index
Active since
2013
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
Brigham and Women's Hospital
University of Birmingham
Ekaterina Pak is an author at Dana-Farber Cancer Institute specializing in molecular oncology, medicine, and oncology.
Publications per year
2013–2019
RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway–Dependent Tumors
Xuesong Zhao, Tatyana Ponomaryov, Kimberly J. Ornell et al. · Cancer Research · 2015 · 167 citations · Full text
Medicine, Cancer Biology, Oncology +17
Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities
Mariella G. Filbin, Sukriti K. Dabral, Maria F. Pazyra‐Murphy et al. · Nature Medicine · 2013 · 150 citations · Full text
Medicine, Cancer Biology, Oncology +16
A Transposon Screen Identifies Loss of Primary Cilia as a Mechanism of Resistance to SMO Inhibitors
Xuesong Zhao, Ekaterina Pak, Kimberly J. Ornell et al. · Cancer Discovery · 2017 · 65 citations · Full text
A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma
Ekaterina Pak, Ethan L. MacKenzie, Xuesong Zhao et al. · Neuro-Oncology · 2019 · 40 citations · Full text
Medicine, Oncology, Pharmacology +15
1–4 of 4